RecruitingNCT06595420

Kidney Function in People With Cystic Fibrosis in the Era of HEMT


Sponsor

University of Virginia

Enrollment

260 participants

Start Date

Jan 9, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

The purpose of this study is to find out what causes kidney disease in people with CF. The investigators will study biomarkers in the blood and urine that can either predict who is at risk or detect kidney damage early before it becomes permanent. The study will compare these markers in people with CF over time and during the treatment of lung flare-ups. It will also compare the blood and urine samples obtained from people without CF. The comparison aims to better understand the impact of cystic fibrosis and its treatment on the kidneys, as well as to develop improved methods for preventing, diagnosing, and treating kidney issues associated with CF.


Eligibility

Min Age: 7 Years

Plain Language Summary

Simplified for easier understanding

This study is looking at how kidney function changes over time in people with cystic fibrosis (CF), particularly now that highly effective new medications (called HEMT, like Trikafta) are widely used. It also includes healthy volunteers for comparison. **You may be eligible if...** - You have been diagnosed with cystic fibrosis - For the outpatient group: you are older than 30 and can give consent - For the inpatient group: you are older than 7, have been hospitalized for a lung infection (pulmonary exacerbation), and can provide a urine sample - For healthy controls: you are between 30 and 50 years old with no known health problems **You may NOT be eligible if...** - You have had an organ transplant or have an immune deficiency - You have a current or previous cancer diagnosis - You are pregnant or breastfeeding - You are currently on dialysis Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(3)

University of Alabama at Birmingham

Birmingham, Alabama, United States

Dartmouth-Hitchcock Geisel School of Medicine at Dartmouth

Lebanon, New Hampshire, United States

University of Virginia Children's Hospital

Charlottesville, Virginia, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06595420


Related Trials